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Abstract
Background: Concerns regarding the privacy of health information are escalating owing both to
the growing use of information technology to store and exchange data and to the increasing
demand on the part of patients to control the use of their medical records. The objective of this
study was to evaluate the Health Care Information Directive (HCID), a recently-developed patient
decision aid that aims to delineate the level of health information an individual is willing to share.
Methods: We convened a series of four focus group meetings with several communities in a large
Canadian city. A total of 28 men and women participated, representing health care consumer
advocates, urban professionals, senior citizens, and immigrants who speak English as a second
language. Data were analysed using qualitative methods.
Results: Participants lacked substantial knowledge regarding the fate and uses of personal health
information. They expressed mistrust concerning how their information will be used and
protected. Several suggestions were made towards customizing the use of data according to
specific needs rather than broad and full access to their charts. Furthermore, despite concern
regarding the implementation of a tool like the HCID, participants were hopeful that a refined
instrument could contribute to the improved regulation of health information.
Conclusion:  This study indicated poor knowledge concerning the uses of personal health
information, distrust concerning security provisions, and cautious support for a patient decision aid
such as the HCID to improve control over health data.
Background
Health information privacy has come to the forefront of
ethical concern in the early 21st century [1]. The advent of
electronic health records, information technology, and
large databases (such as administrative and genetic) with
the potential for extensive linkages have raised concerns
about the security of health information [2,3]. The details
of where such information flows, who has access, and for
what purposes have assumed paramount importance [4-
6].
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Health information is valuable for numerous purposes,
first and foremost for patient care, but also for secondary
uses including hospital administration and health services
research [7,8]. Such non-clinical care uses are required for
system performance and evaluation, as well as to answer
questions about disease trends and health outcomes. In
general, there is a prima facie obligation for the protection
of such intimate and privileged information [4,8]. Scien-
tific surveys and public opinion polls have shown that
access to medical records is generally considered appro-
priate after consent has been obtained for a specific use [9-
12]. Yet, this obligation admits to several exceptions and
there is lack of clarity as to whether express consent is
required for each and every use. Some have argued that
requiring unique individual informed consent for each
use of health information would be burdensome [13-15];
however, there are public opinion data suggesting that
legislative initiatives to require such consent would be
viewed favourably [9].
Internationally, legal initiatives have proposed solutions
to the dilemma posed by health information. In Europe
and North America, such initiatives have led to restrictive
legislation that, according to some commentators, may
endanger public health goods [4,16,17]. A privacy para-
dox thwarting further progress has been identified: indi-
viduals want both the guaranteed privacy of their personal
health information (PHI) and the public benefits that
accrue from the use of medical records [18]. Two distinct
avenues have been proposed for the solution of this para-
dox; the first avenue concentrates on governance issues,
whereas the second promotes the development of tools,
programs, and systems to enhance the lay understanding
of and control over the uses of health data and thereby
facilitate informed consent for secondary uses, as advo-
cated by Mandl and his colleagues [19]. This paper pur-
sues the second avenue.
In 2001, Upshur and Goel first proposed the Health Care
Information Directive (HCID), a patient decision aid
analogous to an advance directive in end-of-life care [20].
The underlying logic was to combine ethical appropriate-
ness of use of PHI with the sensitivity of the data. As
shown in Table 1, the HCID clearly presents the various
permutations and combinations of sensitivity and usage
in the form of a matrix. The goal of the tool is to allow
individuals to make informed choices about the specific
types of health information they are willing to disclose (if
any) for a number of specified purposes.
In the original proposal, it was stated that pilot testing of
the tool, and revision on the basis of such testing, is
required [20]. In order to assess the feasibility of imple-
menting the HCID, two segments of the population were
studied: the general lay public and privacy experts such as
ethicists, academics, and provincial privacy commission-
ers. In this paper, we report the results of the study con-
ducted with the general public. Specifically, our objective
was to investigate lay knowledge of the uses and accesses
of health information and to solicit feedback on the pro-
totype of the HCID.
Methods
Participants and setting
The study was set in Toronto, Canada, a large, culturally-
diverse urban centre. In order to sample multiple views
and perspectives, a series of focus group meetings was
convened with the following four groups: senior citizens,
urban professionals, immigrants with English as a second
language, and consumer advocates. The latter group was
comprised of volunteer members of a well-known
national consumer advocacy association for which health
care is an issue of primary interest and activity. We opted
to employ focus group methodology as opposed to indi-
vidual interviews or a questionnaire survey in order to
capitalize on the effects of group interaction. These partic-
ular communities or target groups were selected in order
to maximize the variability within our sample on impor-
tant demographic characteristics such as age, gender,
occupation, education, and native language, etc. (availa-
ble funding allowed for a total of four focus groups).
Potential participants were recruited using various meth-
ods: the seniors were recruited through a local community
centre offering programs for senior citizens; participants
in the immigrant/ESL group were recruited through an
immigrants group at another community centre; the
urban professionals were recruited by way of posters and
fliers distributed at a number of hospitals and university
sites; and the advocates were recruited through a national
consumer advocacy association. In all cases, initial contact
with potential participants was made either by telephone
or e-mail and then followed up with formal letters of invi-
tation describing the project. The focus group meetings
were held in a convenient location for the participants
and lasted for up to two hours.
We developed a topic guide for the focus group meetings
in order to address the main issues related to the feasibil-
ity of the HCID (see Appendix 1). The topic guide was
developed according to the principles of formative evalu-
ation (also known as 'developmental' evaluation) [21].
Focus group participants were initially questioned regard-
ing their understanding of health information and its
uses. Participants were then introduced to the HCID,
which was presented as a patient decision aid currently
under development by "university researchers." Partici-
pants were informed that their feedback and suggestions
would guide the continuing refinement of the tool and
were asked to be as candid as possible. Following a brief
period of approximately 5–10 minutes in which partici-BMC Medical Informatics and Decision Making 2004, 4:13 http://www.biomedcentral.com/1472-6947/4/13
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pants examined the HCID and jotted down any ques-
tions/concerns/suggestions, participants were asked to
share their thoughts on its relative strengths and limita-
tions. As per the topic guide, issues of content, utility, and
feasibility were addressed in turn, followed by a discus-
sion of perceived benefits and burdens. At the end of each
meeting, participants were provided an opportunity to
raise any issues or concerns that had not been previously
addressed.
Two of the authors (GCD and CST) moderated the four
focus group meetings, which lasted 90 minutes on aver-
age. A total of 28 participants took part (see Table 1 for a
description of the sample). The meetings were audio-
recorded with participants' consent and transcribed verba-
tim by a professional transcriptionist. To ensure accuracy
and to clarify any muffled passages, all transcripts were
verified by one of the two group moderators. Participants
received an honorarium of $50 for their time, in addition
to transportation costs.
The study was approved by the Research Ethics Board at
Sunnybrook and Women's College Health Sciences Cen-
tre and the Office of Research Services at the University of
Toronto. All participants signed and returned a consent
form.
Data analysis
The analytic process was one of thematic content analysis.
The topic guide developed for the focus group meetings
served as the basis for the data analysis process. Two of the
authors (GCD and CST) independently read each of the
transcripts and identified passages of text relating to each
of the various key issues from the topic guide (e.g., con-
tent, utility, benefits, etc.) which, for the purposes of cod-
ing and analysis, served as the macro-codes. Following
this step, lists of themes were constructed and then com-
pared. The transcripts were then independently coded
according to an agreed-upon coding scheme. Tests for
inter-coder reliability indicated a high level of agreement
among the two coders; instances of disagreement were
resolved through a process of discussion and negotiation.
To strengthen the validity of the findings, the analytic
processes of coding and interpretation were reviewed by
the senior author (REGU). The results of our analysis are
reported according to five key themes: participant knowl-
edge and understanding of health information and its
uses; control of access to health data; mistrust of data
security provisions; need and utility for a tool such as the
HCID; and, finally, perceived implementation barriers.
Consenus statements reported below are not a reflection
of any explicit consensus development techniques, but
rather are summary statements of the research team's
observation and interpretation of the focus group discus-
sions. For each quotation, a specific code is provided to
identify the speaker as a participant in one of the four
focus groups (CA = consumer advocate; IM = immigrant;
SC = senior citizen; and UP = urban professional).
Results
Knowledge and understanding
The majority of participants possessed extremely limited
knowledge of how their PHI is collected, used, and dis-
closed. Many confessed to having given little or no
thought to the issues involved in the health privacy
debate. This was particularly true for recent immigrants: "I
think the truth is that I don't know. I've never thought of
that before, who has my information."(IM-1). The level of
understanding was low among participants in other
groups as well, as a number of comments betrayed basic
misperceptions of how PHI is currently managed within
the Canadian health care system:
"It [personal health information] goes in the computer
and then it's available to every medical professional in
Ontario." (SC-3)
"Health providers have access to your file, to your infor-
mation... but everybody in the financial department, too,
because they have to bill OHIP [Ontario Health Insurance
Program] so they have to know everything about you."
(IM-2)
One participant perceptively noted that the general popu-
lation has limited knowledge of the issue of health
privacy:
Table 1: Demographic characteristics of focus group participants








Urban professionals 8 4:4 30–39 yrs 8
Immigrants (ESL) 7 2:5 40–49 yrs 5
Health advocates 6 2:4 50–59 yrs 6
Senior citizens 7 0:7 >70 yrs 1BMC Medical Informatics and Decision Making 2004, 4:13 http://www.biomedcentral.com/1472-6947/4/13
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"That's another thing. What do people know about what
they can get access to, what they can ask for, and what they
can expect? I think the majority of the population have no
idea of what they can ask for and expect to get." (CA-4)
Control of access
Participants' accounts clearly suggested an absence of
patient control over the collection, use, and disclosure of
PHI. No participants recalled having ever been consulted
about how their information was to be used. A great deal
of concern was voiced about the extent to which health
data appears to be freely accessible to a wide variety of
users: "Lawyers, psychologists, social workers, researchers,
pharmaceutical companies. Where does it stop?" (UP-4).
In the course of describing how they feel about the issue
of health privacy, participants repeatedly used terms such
as "scary" and "horrifying":
"I'm scared to guess who has [access to my health infor-
mation]. It looks so easy for a lot of people to have access.
That's the scary part of it. Maybe your employer can have
access to your files, too. I don't know, that's just a guess."
(IM-6)
The majority of participants expressed concern that their
PHI is not adequately safe-guarded and that the imple-
mentation of a tool such as the Health Care Information
Directive would not result in significantly enhanced pri-
vacy or increased security. There was a widespread view
that too much data is currently made available when only
specific details are required. Doubts were raised about
how consent for one specific use only would be managed:
"What's going to prevent any leaking from one of these
[uses] into the others? ... It just seems to me that if there's
information on-line, things are going to be compromised.
You know, people make a living doing that stuff. The
more they find out about you, the more you can be
exploited. It's that simple. These systems, they're not
secure yet, and I don't know if they can ever be secure."
(UP-3)
Health privacy concerns related to the security of elec-
tronic databases and the Internet were shared by others:
"We've all heard stories where there's been stolen identi-
ties. How difficult is it for the victim to get his or her own
identity back? Same idea. Where does it end? Where does
it stop? Who's got what information? How am I going to
protect myself?" (UP-6)
Participants suggested a number of other mechanisms
that could work in conjunction with the HCID to enhance
security and facilitate individual control over PHI. One
such mechanism would be an online real-time audit sys-
tem in which the details of all accesses to an individual's
PHI are recorded and made available to those wishing to
track access to their PHI over time. Also, the idea of a
health data ombud was raised in several groups and
received a great deal of support.
Mistrust
Issues related to trust were raised in each of the four
groups. Participants of all ages and socioeconomic status
expressed feelings of mistrust in relation to the protection
of their privacy and the security of their PHI. A great many
participants spoke of how their past experiences with the
health care system have fostered significant mistrust and
suspicion where their right to privacy is concerned. These
accounts revealed a growing distress that large corpora-
tions have too much access to and influence on govern-
ment programs, especially in contrast to the access and
influence accorded to patients:
"What about the rights of the patient? Let's say I'm the
patient. What kind of power do I have? Let's say this [the
HCID] was created next year. What power does the patient
have to make sure any of this is happening? To me, a phar-
maceutical company is way more powerful than the
patient." (CA-2)
Others were even more sceptical, questioning the trust-
worthiness of the basic tenets of the model upon which
the HCID is based:
"By filling this out, I'm buying into the concept of sharing
information, but I don't have any faith that it can be kept
private.... It will spill, it will bleed, it will flow. So I'm dis-
trustful of the whole thing. This just sets up more spilling
and more flowing. If I fill out a form like this, then I'm val-
idating the process, which I don't really trust." (UP-8)
Need and utility
While the majority were sceptical that the HCID would
prevent all breaches of privacy, there was a general con-
sensus that it would serve to enhance significantly the
security of health data. One participant noted that the
proposed decision aid may also serve a useful purpose as
"a sort of consciousness raising" tool. Other impressions
varied from "it has some potential" to "it is a great step
forward." Reactions were mixed in response to the ques-
tion of whether the HCID will be successful in empower-
ing individuals and increasing the amount of control over
PHI:
"I'm very dubious as to whether this matrix will be useful
because of the difficulty people will have filling it out. In
spite of that, I think the idea has merit and principle.
There's merit in what you're trying to do, but I don't think
that this is going to succeed." (CA-5)BMC Medical Informatics and Decision Making 2004, 4:13 http://www.biomedcentral.com/1472-6947/4/13
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"I guess the reality is our information will be shared, so we
might as well get on the bandwagon with regulating it and
controlling it... You can't stop it from being shared, so
maybe you can influence how it will be shared." (UP-2)
Despite the weaknesses and limitations of the present ver-
sion of the directive, one participant neatly summarized
the view of the majority of participants regarding the util-
ity of the HCID or some such tool: "Not having it allows
total absence of control, therefore it is a necessary evil."
(CA-4).
Implementation barriers
Participants provided numerous suggestions regarding the
formatting of the HCID in order to facilitate implementa-
tion. Ideas ranged from simplifying the language and pro-
viding definitions of technical terms to modifying the
layout and shading those areas where there is no discre-
tion (i.e., for physician payment):
"Maybe you've got too many columns.... Well, maybe
you're trying to do too many different things at once."
(CA-4)
"This is too busy, it's too much. If I'm sick, I friggin' don't
want to be bothered with it.... Look at this. English is my
first language. How would somebody whose mother
tongue is something other than English? It's too compli-
cated." (SC-1)
"I think people tend to say 'no' for things that are not
clear. I would say 'yes' if I knew what it means exactly, but
I don't know, so I don't want to take a chance." (IM-1)
To address the complexity issue, suggestions were made
concerning the need to provide a customer service repre-
sentative either in a health clinic or via a toll-free helpline
for assistance with completing the HCID.
Across the four groups, there was great variability in the
preferred mode of implementation. The preference
among participants in the health advocates and urban
professional groups was for an on-line implementation
format. In contrast, the majority of the senior citizens and
immigrants preferred other options, the former favouring
a postal format and the latter the primary care setting. As
one senior citizen remarked: "I prefer the doctor's office. I
wouldn't fill it and send it back through the mail, no."
(SC-3)
Discussion
A recent editorial in the British Medical Journal suggested
that perhaps patients should be asked whether certain
items of their medical chart should only be shared with
specified individuals or organizations or only for pre-
determined purposes [16]. This paper reports the evalua-
tion of the feasibility of a tool that seeks to accomplish
exactly that purpose, namely, greater patient control over
how personal health information is used and disclosed.
Study participants lacked substantial knowledge regarding
the fate and uses of PHI within a publicly-funded health
care system. Participants expressed mistrust concerning
how their PHI is used and safe-guarded. Several sugges-
tions were made towards customizing the use of data
according to specific needs rather than broad and full
access to their charts. Furthermore, concerns were
expressed regarding the implementation of a tool such as
the HCID. Nevertheless, there was hope that a refined
instrument could contribute to improved data manage-
ment and regulation and enhanced privacy protection.
Although this study reports on a small sample from a sin-
gle large urban centre, the focus group participants were
drawn from various different niches of Canadian society.
This sampling strategy allowed us to explore a broad range
of experiences and perspectives; however, further testing
and evaluation are required. Ultimately, it will be neces-
sary to evaluate the tool using a representative sample of
patients who complete the HCID in a 'live' test of its
feasibility.
Our findings underscore the difficulties involved in
accessing health care data for research and other second-
ary purposes. Participants acknowledge the myriad bene-
fits derived from the use of health data; however, distrust,
lack of respect, and insufficient patient control of the
process threaten to undermine these very benefits. This
finding has been previously reported by Willison and
associates in Canada [22] and by Robling and colleagues
in the UK [12]. The present results also suggest that the
education and information needs of diverse groups such
as seniors and immigrants who speak English as a second
language should be taken into account when considering
strategies to enhance individual control over PHI and
minimize the problem of authorization bias when utiliz-
ing health information for secondary purposes.
Participants appreciated the benefits accorded by a tool
such as the HCID. As opposed to forms of blanket consent
or other opt in/opt out models, the possibility of exerting
greater control over one's PHI was attractive. The partici-
pants provided concrete suggestions for improving the
format and content of the HCID. It is evident that any
method to enhance control of health information via
explicit consent requires description of the various forms
the data may take, the specific purposes for which the data
would be used, and the various channels of the health care
system through which the data might flow. To our knowl-
edge, such detailed data flowmaps for PHI do not exist inBMC Medical Informatics and Decision Making 2004, 4:13 http://www.biomedcentral.com/1472-6947/4/13
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Canada, although they have been laid out in Great Britain
[23]. A model has been proposed by Schoenberg and
Safran [24]. The creation of such maps is of high priority.
An intriguing finding was the appeal of an online data
audit system. Possessing the ability to monitor who has
accessed their PHI and for what purposes raises the possi-
bility of additional strategies that could empower individ-
uals to control the fate of their health information. This
finding has also been verified by Pyper and colleagues
[25] and was previously highlighted by MacDonald [26].
As well, the concept of a data ombudsperson was consid-
ered attractive to a number of participants, indicating that
an improved governance framework would be acceptable
to some segments of the population.
Finally, there is a distinction to be made between using
the HCID to enforce the will of the patient versus its use
as a documentation tool. Our vision is that the HCID will,
ultimately, serve both of these important functions; fur-
ther follow-up evaluation of a revised model of the HCID
using a larger sample (comprised of patients as well as
providers) is needed to address this distinction. As with
any patient decision aid or empowerment tool, docu-
menting the preference of the patient is only meaningful
and useful to the extent that the documented preferences
are known and ultimately acted upon by those providing
care. We believe the present data illustrate the critical
problem of mistrust that currently exists. Indeed, this is
one of the greatest challenges to be overcome in the con-
tinuing development and validation of this tool.
Conclusion
This study indicated poor knowledge concerning the uses
of health data, distrust concerning current security provi-
sions, and qualified support for a tool such as the HCID
to improve patient control over health information. On
the basis of this evaluation, the HCID will be revised sig-
nificantly, including the addition of an educational com-
ponent, and then submitted to further evaluation. The
creation of data flowmaps and the exploration of audit
functions and governance structures are strongly recom-
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Appendix 1
FOCUS GROUP TOPIC GUIDE: EVALUATION OF THE 
'HEALTH CARE INFORMATION DIRECTIVE'
A. Personal Health Information
1. What is your understanding of the term 'personal
health information'?
2. Who do you believe has access to your personal health
information?
3. Do you believe that consent should be required to
access your personal health information?
B. Content
1. What is your first impression of the Health Care Infor-
mation Directive?
2. Is it clear?
3. Is it self-explanatory?
C. Utility
1. How useful do you believe the Health Care Information
Directive would be in practice?
2. Is it user-friendly?
3. What kind of changes would you suggest?
D. Feasibility
1. How feasible is the application of the Health Care
Information Directive?
2. Who should present it to the patient?
3. When should it be presented to the patient?
E. Benefits and Burdens
1. What are the potential gains of the Health Care Infor-
mation Directive?
2. What are the potential harms?
3. Does it adequately protect privacy and confidentiality?
F. Additional Comments
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